# A Randomized, Double-Blind, Active Control Trial Comparing Effects of Telmisartan, Candesartan and Amlodipine, Alone or Plus Metformin, on Non-Diabetic, Obese Hypertensive Patients

> **NCT00538486** · PHASE4 · COMPLETED · sponsor: **Third Military Medical University** · enrollment: 360 (actual)

## Conditions studied

- Hypertension
- Obesity

## Interventions

- **DRUG:** Telmisartan plus Metformin
- **DRUG:** Telmisartan
- **DRUG:** Candesartan
- **DRUG:** Candesartan plus Metformin
- **DRUG:** Amlodipine
- **DRUG:** Amlodipine plus Metformin

## Key facts

- **NCT ID:** NCT00538486
- **Lead sponsor:** Third Military Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2009-06
- **Final completion:** 2009-06
- **Target enrollment:** 360 (ACTUAL)
- **Last updated:** 2013-05-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00538486

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00538486, "A Randomized, Double-Blind, Active Control Trial Comparing Effects of Telmisartan, Candesartan and Amlodipine, Alone or Plus Metformin, on Non-Diabetic, Obese Hypertensive Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00538486. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*